National and Kapodistrian University of Athens
Ασφάλεια και αποτελεσματικότητα της διαδερμικής θερμοκαυτηρίασης με ραδιοσυχνότητες σε ασθενείς με ανεγχείρητες ηπατικές μεταστάσεις από αδενοκαρκίνωμα του παχέος εντέρου
Abstract
dc:descriptionDespite the advent of combination chemotherapy regimens achieved within the last decade, long term survival of patients with unresectable metastatic disease from colorectal cancer remains poor. Thermal ablation procedures, including radiofrequency ablation (RFA), are considered feasible options in treating unresectable hepatic tumors either primary (hepatocellular carcinoma) or metastatic, the latter mainly arising from colorectal cancer. Percutaneous access is the least invasive RFA procedure. Local ablation therapies of hepatic tumors have become increasingly popular. Their advantages of outpatient management, low morbidity and synergy with chemotherapy are coupled with evidence that their scope extends beyond palliation for selected patients. However, there is still debate on optimal time and patient selection, and the published literature lacks randomized data on efficacy compared to chemotherapy alone.We performed a retrospective, case-controlled study of patients with colorectal liver metastases that were treated with percutaneous radiofrequency (RF) or microwave (MW) thermal ablation (cases). We assigned 28 consecutive patients treated with RFA or MW to an age-sex matched group of patients with comparable characteristics that received chemotherapy only.A total of 55 sessions (52 RF, 3 MW) were performed among cases, with minimal procedural time (median 8 min), zero mortality and no severe complications (3 cases of local hepatic hematoma not requiring hospitalization). Thermal ablation was associated with prolonged median progression-free survival (PFS, 19.4 months) and overall survival (OS, 27.5 months) over controls (14.0 and 21.4 months, respectively). After adjusting for hepatic involvement, PFS estimates were similar between the two groups and OS was better for the ablated group. One and 2-year survival estimates were 0.96 and 0.79, respectively for thermal ablation patients compared to 0.82 and 0.52 for controls. In summary, percutaneous thermal ablation procedures may add significantly to the management of patients with colorectal liver metastasis, delaying disease progression and death. Importantly, the improvement of systemic therapies may expand the pool of candidate patients for modern local therapies rather than diminish it. Thermal ablation should be considered a significant improvement in the multidisciplinary approach of patients with colorectal cancer and limited hepatic involvement.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Poulou, Loukia
- Πούλου, Λουκία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42027